| 0 (0%) | 04-19 01:55 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 4.76 | 1-year : | 5.56 |
| Resists | First : | 4.07 | Second : | 4.76 |
| Pivot price | 2.91 |
|||
| Supports | First : | 2.97 | Second : | 2.29 |
| MAs | MA(5) : | 3.44 |
MA(20) : | 2.82 |
| MA(100) : | 1.33 |
MA(250) : | 0.98 |
|
| MACD | MACD : | 0.3 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 80.1  |
D(3) : | 84.8 |
| RSI | RSI(14): 72.2 |
|||
| 52-week | High : | 4.07 | Low : | 0.21 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ JAN ] has closed below upper band by 7.1%. Bollinger Bands are 166.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 3.7 - 3.72 | 3.72 - 3.74 |
| Low: | 3.26 - 3.28 | 3.28 - 3.29 |
| Close: | 3.67 - 3.7 | 3.7 - 3.73 |
Wed, 03 Apr 2024
Local students win UNLV scholarship in business pitch competition - News3LV
Mon, 19 Jun 2023
Christine Juarez, JASN, and Ken Edwards, Volunteer of the Year winner - Nevada Business Magazine
Thu, 25 May 2023
American Society of Nephrology Names Rajnish Mehrotra Editor-in-Chief of JASN and Senior Editor-in-Chief for the ... - Newswise
Wed, 28 Dec 2022
Journal of the American Society of Nephrology - LWW Journals
Wed, 26 Oct 2022
Activation of the transcription factor XBP1 reduces severity of polycystic kidney disease - Medical Xpress
Wed, 17 Aug 2022
Age-Related Kidney Function Loss Differs Significantly by Gender - Medpage Today
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 9 (M) |
| Shares Float | 8 (M) |
| Held by Insiders | 6.6 (%) |
| Held by Institutions | 5.3 (%) |
| Shares Short | 251 (K) |
| Shares Short P.Month | 190 (K) |
| EPS | -4.27 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.68 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -9.1 % |
| Return on Equity (ttm) | -122.1 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -0.39 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 1 (M) |
| Levered Free Cash Flow | -10 (M) |
| PE Ratio | -0.87 |
| PEG Ratio | 0 |
| Price to Book value | -5.53 |
| Price to Sales | 0 |
| Price to Cash Flow | 21.76 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|